Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Relaxin · 2 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| Placebo | PLACEBO_COMPARATOR | 48 hour iv infusion of placebo |
| Relaxin | EXPERIMENTAL | 48 hour iv infusion of relaxin at 30 ug/kg/day |
| Name | Type | Description |
|---|---|---|
| Relaxin | DRUG | Intravenous infusion for 48 h at 30 ug/kg/day |
| Placebo | DRUG | Intravenous infusion for 48 h |
Inclusion Criteria: * Hospitalized for acute heart failure * Dyspnea at rest or with minimal exertion * Pulmonary congestion * Able to provide informed consent * Systolic blood pressure \> 125 mmHg * Impaired renal function defined as an eGFR of 30-75 mL/min/1.73m2 Exclusion Criteria: * Use of ot...